Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bolmström A[au]:

The E-Test as an epidemiologic tool. Baquero F et al. Diagn Microbiol Infect Dis. (1992)

Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. Walsh TR et al. J Clin Microbiol. (2001)

A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. Garnier F et al. J Antimicrob Chemother. (2006)

Search results

Items: 26

1.

Rapid 4 to 6 hour detection of extended-spectrum beta-lactamases in a routine laboratory.

Ercis S, Sancak B, Kocagöz T, Kocagöz S, Hasçelik G, Bolmström A.

Scand J Infect Dis. 2007;39(9):781-5.

PMID:
17701716
2.

Validation and reproducibility assessment of tigecycline MIC determinations by Etest.

Bolmström A, Karlsson A, Engelhardt A, Ho P, Petersen PJ, Bradford PA, Jones CH.

J Clin Microbiol. 2007 Aug;45(8):2474-9. Epub 2007 May 23.

3.

Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar.

Skov R, Smyth R, Larsen AR, Bolmstrôm A, Karlsson A, Mills K, Frimodt-Moller N, Kahlmeter G.

J Clin Microbiol. 2006 Dec;44(12):4395-9. Epub 2006 Oct 18.

4.

A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital.

Garnier F, Chainier D, Walsh T, Karlsson A, Bolmström A, Grelaud C, Mounier M, Denis F, Ploy MC.

J Antimicrob Chemother. 2006 Jan;57(1):146-9. Epub 2005 Nov 14. Erratum in: J Antimicrob Chemother. 2006 Mar;57(3):583.

PMID:
16286482
5.

Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp.

Lee K, Yong D, Yum JH, Lim YS, Bolmström A, Qwärnström A, Karlsson A, Chong Y.

J Clin Microbiol. 2005 Feb;43(2):942-4.

6.

Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin?

Ng LK, Sawatzky P, Galas M, Rodrigues Ddos P, Heitmann I, Fernandez S, Bolmström A.

Antimicrob Agents Chemother. 2003 Apr;47(4):1479-80. No abstract available.

7.

Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).

Bolmstrom A, Ballow CH, Qwarnstrom A, Biedenbach DJ, Jones RN.

Clin Microbiol Infect. 2002 Dec;8(12):791-800.

8.

Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing.

Walsh TR, Bolmström A, Qwärnström A, Gales A.

J Clin Microbiol. 2002 Aug;40(8):2755-9.

9.

Influence of CO(2) incubation on quinolone activity against Streptococcus pneumoniae and Haemophilus influenzae.

Bolmstrom A, Karlsson A.

Diagn Microbiol Infect Dis. 2002 Jan;42(1):65-9.

PMID:
11821174
10.

Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.

Pfaller MA, Messer SA, Mills K, Bolmström A, Jones RN.

J Clin Microbiol. 2001 Dec;39(12):4387-9.

11.

Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species.

Pfaller MA, Messer SA, Mills K, Bolmström A, Jones RN.

J Clin Microbiol. 2001 Nov;39(11):3952-4.

12.

Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.

Walsh TR, Bolmström A, Qwärnström A, Ho P, Wootton M, Howe RA, MacGowan AP, Diekema D.

J Clin Microbiol. 2001 Jul;39(7):2439-44.

13.

Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest.

Peyron F, Favel A, Michel-Nguyen A, Gilly M, Regli P, Bolmström A.

J Clin Microbiol. 2001 Jan;39(1):339-42.

14.

Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.

Bobin-Dubreux S, Reverdy ME, Nervi C, Rougier M, Bolmström A, Vandenesch F, Etienne J.

Antimicrob Agents Chemother. 2001 Jan;45(1):349-52.

15.
16.
17.

Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B.

Pfaller MA, Messer SA, Bolmström A.

Diagn Microbiol Infect Dis. 1998 Nov;32(3):223-7.

PMID:
9884840
18.
19.

Antimicrobial Susceptibility of Klebsiella pneumoniae Producing Extended-Spectrum beta-lactamase (ESBL) Isolated in Hospitals in Brazil.

Gales AC, Bolmström A, Sampaio J, Jones RN, Sader HS.

Braz J Infect Dis. 1997 Aug;1(4):196-203.

PMID:
11105137
20.

Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.

Pfaller MA, Messer SA, Bolmström A, Odds FC, Rex JH.

J Clin Microbiol. 1996 Jul;34(7):1691-3.

21.
22.

Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.

Hoffner SE, Klintz L, Olsson-Liljequist B, Bolmström A.

J Clin Microbiol. 1994 Aug;32(8):1846-9.

23.
24.

Susceptibility testing of anaerobes with Etest.

Bolmström A.

Clin Infect Dis. 1993 Jun;16 Suppl 4:S367-70. No abstract available.

PMID:
8324149
25.

The E-Test as an epidemiologic tool.

Baquero F, Cantón R, Martinez-Beltrán J, Bolmström A.

Diagn Microbiol Infect Dis. 1992 Jul;15(5):483-7.

PMID:
1643830
26.

Evaluation of the E-Test for susceptibility testing of pneumococci.

Jacobs MR, Bajaksouzian S, Appelbaum PC, Bolmström A.

Diagn Microbiol Infect Dis. 1992 Jul;15(5):473-8.

PMID:
1643828

Supplemental Content

Loading ...
Support Center